Zobrazeno 1 - 10
of 769
pro vyhledávání: '"Mark, Crowther"'
Autor:
Roger Kou, Lucy Zhao, Daniel Tham, Rachael Principato, Giovanna Schünemann, Aqib Mannan, Mark Crowther
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 651-660 (2024)
Abstract Immune thrombocytopenic purpura (ITP) is an immune disorder characterized by thrombocytopenia. Fostamatinib is an orally administered spleen tyrosine kinase inhibitor intended to treat refractory ITP. To evaluate the efficacy and safety of f
Externí odkaz:
https://doaj.org/article/1ee7b8ecbb28448f921a4319613dfec2
Autor:
MacKenzie Horn, Ankur Banerjee, Linda Kasickova, Ondrej Volny, Hyun Seok Choi, Federica Letteri, Tomoyuki Ohara, Koji Tanaka, Stuart Connolly, Per Ladenvall, Mark Crowther, Jan Beyer‐Westendorf, Ashkan Shoamanesh, Andrew M. Demchuk, Abdulaziz S. Al Sultan, for the ANNEXa‐4 Investigators
Publikováno v:
Brain and Behavior, Vol 14, Iss 5, Pp n/a-n/a (2024)
Abstract Background and purpose The ANNEXA‐4 trial measured hemostatic efficacy of andexanet alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was traumatic and nontraumatic intracranial bleeding. Different meas
Externí odkaz:
https://doaj.org/article/ff1fa63f153a4ca89ede25b0acd294e1
Autor:
Saurabh Gupta, Charlotte C. McEwen, Winston Hou, Mark Crowther, Deborah Siegal, John Eikelboom, Richard P. Whitlock, Emilie P. Belley-Côté
Publikováno v:
Thrombosis Update, Vol 14, Iss , Pp 100164- (2024)
Introduction: For patients with mechanical aortic valves, guideline recommended INR targets range from 2.0 to 3.5, depending on thromboembolic risk factors. Supporting data is largely historical and of low quality. We aimed to characterize clinicians
Externí odkaz:
https://doaj.org/article/6dda384f619e4fbbb0ac017d64f2098c
Autor:
Lucy Zhao, Daniel Tham, Wendy Yu, Jayhan Kherani, Allen LI, Pei Ye LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e974141e (2023)
Externí odkaz:
https://doaj.org/article/0d4db29f03e54eff9943c181e2c1a691
Publikováno v:
HemaSphere, Vol 7, p e1167638 (2023)
Externí odkaz:
https://doaj.org/article/d7c47023ef994fdda51dd4a342b16bb8
Autor:
Wenhui Yu, Jayhan Kherani, Lucy Zhao, Daniel Tham, Allen LI, Harry LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e200448c (2023)
Externí odkaz:
https://doaj.org/article/2c60bdf393d0446aaf9c00e34f68aef6
Autor:
Lucy Zhao, Jayhan Kherani, Pei Ye LI, Kevin Zhang, Angelina Horta, Christine Lin, Allen LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e8567529 (2023)
Externí odkaz:
https://doaj.org/article/e790d887582041efb12c2fdc78768ac2
P1665: USE OF DOACS IN THE MANAGEMENT OF UPPER EXTREMITY DEEP VENOUS THROMBOSIS; A SYSTEMATIC REVIEW
Publikováno v:
HemaSphere, Vol 7, p e2856211 (2023)
Externí odkaz:
https://doaj.org/article/ebebee90c3db4160aea0128bf81c3f0e
Publikováno v:
HemaSphere, Vol 7, p e0223224 (2023)
Externí odkaz:
https://doaj.org/article/8e8034a5a1b24c90a5aa67d0f7e10dfc
Autor:
Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu, Agnes Y. Y. Lee
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5434-5451 (2021)
Patients with cancer-associated thrombosis (CAT) are at high risk of recurrent venous thromboembolism (VTE) and major bleeding complications. Risks vary significantly between individuals based on cancer status, treatment, and other characteristics. T
Externí odkaz:
https://doaj.org/article/f8bf6815f81f4b45a5ac232a09ac3b2b